ScholarIQanswers from OpenAlex
Siemens Healthcare (United States)
InstitutionResearch output, impact & collaborations
Siemens Healthcare (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Siemens Healthcare (United States)?
ScholarIQrecord summary
Siemens Healthcare (United States) is a research organisation in Malvern, US. OpenAlex records 5,851 works and 253,563 citations for it. 1,686 researchers list it as their most recent affiliation.
How many works does Siemens Healthcare (United States) have?
ScholarIQindexed works
Siemens Healthcare (United States) has 5,851 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Siemens Healthcare (United States) have?
ScholarIQcitation count
Siemens Healthcare (United States) has 253,563 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Siemens Healthcare (United States)?
ScholarIQresearcher count
Siemens Healthcare (United States) has 1,686 researchers in the ScholarIQ index.
What is the average h-index at Siemens Healthcare (United States)?
ScholarIQavg h-index
Siemens Healthcare (United States) has an average h-index of 49 in OpenAlex.
What is the ROR of Siemens Healthcare (United States)?
ScholarIQror
The ROR for Siemens Healthcare (United States) is on the source record.
What is the OpenAlex record for Siemens Healthcare (United States)?
ScholarIQopenalex
The OpenAlex for Siemens Healthcare (United States) is on the source record.
Who are the most-cited researchers behind Siemens Healthcare (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Siemens Healthcare (United States)?
ScholarIQmost cited works
DNA repair pathways as targets for cancer therapy
Thomas Helleday, Eva Petermann, Cecilia Lundin, Ben Hodgson, Ricky A. Sharma
Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium
Andrew S. Kennedy, Subir Nag, Riad Salem, Ravi Murthy, Alexander McEwan, Charles Nutting, Al B. Benson, Joseph Espat, José Ignacio Bilbao, Ricky A. Sharma, James P. Thomas, Douglas M. Coldwell
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Harpreet Wasan, Peter Gibbs, Navesh Sharma, Julien Taı̈eb, Volker Heinemann, Jens Ricke, Marc Peeters, Michael Findlay, Andrew Weaver, Jamie Mills, Charles Wilson, Richard Adams, Anne Francis, Joanna Moschandreas, Pradeep S. Virdee, Peter Dutton, Sharon Love, Val Gebski, Alastair Gray, Richard Adams, Andrew Bateman, Claire Blesing, Ewan Brown, Ian Chau, Sebastian Cummins, David Cunningham, Stephen Falk, Maher Hadaki, Marcia Hall, Tamas Hickish, Joanne Hornbuckle, F. Lofts, Sarah Lowndes, Astrid Mayer, Matthew S. Metcalfe, Gary Middleton, Jamie Mills, Amir Montazeri, R. Muirhead, Andreas Polychronis, Colin Purcell, Paul J. Ross, Ricky A. Sharma, Liz Sherwin, David Smith, Rubin Soomal, Daniel Swinson, Axel Walther, Harpreet Wasan, Andrew Weaver, Charles Wilson, Greg Wilson, Pradip Amin, Bruna Angelelli, Jacques Balosso, Alex Beny, Daniel Bloomgarden, Evelyn Boucher, Michael D. Brown, Harald-Robert Bruch, James Bui, Matthew Burge, Giuseppe Cardaci, James Carlisle, Seungjean Chai, Yi‐Jen Chen, P. Chevallier, Michael Chuong, Stephen Clarke, Andrew L. Coveler, M Craninx, Thierry Delanoit, Amélie Deleporte, Paul Eliadis, Francis Facchini, Thomas W. Ferguson, Michel Ferrante, Michael Findlay, Gary Frenette, Jacob Frick, Vinod Ganju, Michael Garofalo, Karen Geboes, Gerald Gehbauer, Benjamin George, Ravit Geva, Peter Gibbs, Melita A. Gordon, Kate Gregory, Seza A. Güleç, James Hannigan, Guy van Hazel, Norman Heching, Volker Heinemann, Thomas Helmberger, Alain Hendlisz, Koen Hendrickx, Matthew P. Holtzman, Richard Isaacs, Christopher Jackson
How much of the research on Siemens Healthcare (United States) is open access?
ScholarIQopen access share
33%OPEN ACCESS